Categories
Pharmaceutical

Market Outlook of Laboratory Information Management Systems (LIMS) will Remain Pragmatic with a CAGR of Over 7% until 2031

Prolific developments in life sciences, characterized by rapid AI penetration, industry-wide proliferation of cloud technology, and possible therapeutic connotations of previously contraband substances such as marijuana are amongst some key developments that have led to the emergence of a trillion dollar global pharmaceutical industry in recent years. This has eventually led to swift automation of laboratory settings, providing credible stimulus to the global lab automation market, according to a recent report published by consulting firm Fact.MR.

According to the report, the market is poised to experience significant gains, posting a CAGR exceeding 7% through 2031. Increasing number of grants disbursed to facilitate advanced drug development & clinical diagnostic research is responsible for bulk of the market’s growth. For instance, the EU Commission, in March 2021, advanced a grant to eTheRNA Immunotherapies, to accelerate the development of a novel and potentially best-in-class therapeutic mRNA cancer vaccine to treat recurrent HPV16+ head and neck cancers. The grant amounted to € 6.9 million.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=5672

Growth prospects have further heightened since the onset of COVID-19, with healthcare providers scrambling to deploy precise and advanced diagnostic services, as well as accelerate drug and vaccine development. Consequently, overall healthcare spending rose to US$ 1.4 trillion, representing over 30% increase since 2015. Additionally, a host of government initiatives in key markets have greatly helped augment spending on lab automation, a trend likely to continue over the coming years.

Key Companies Profiled

  • Thermo Fisher Scientific
  • Agilent Technologies
  • PerkinElmer
  • Hudson Robotics
  • Qiagen NV
  • F. Hoffmann-La Roche Ltd.
  • Hamilton Robotics
  • Siemens Healthineers
  • Becton Dickinson and Company
  • Bio-Rad Laboratories

Key Takeaways from Market Study

  • By product, demand for integrated automated workstations to expand at a rapid pace
  • Biotechnology & pharmaceutical industry experiencing major uptake of lab automation systems
  • By application, drug discovery and clinical diagnostics to collectively capture a lucrative share
  • Voluminous biopharmaceuticals manufacturing to elevate lab automation deployment across the U.S.
  • The U.K. to generate fresh revenue ecosystems amid high reliance on in vitro diagnostics
  • Growing R&D initiatives by government and non-governmental entities bolstering France and Germany’s growth prospects
  • India and China to emerge as lucrative hotspots amid increasing need to offset asymmetries in efficient lab testing mechanisms

“Growing irregularities in quality diagnosis & drug development due to high error margins are prompting healthcare providers to invest in the most contemporary lab automation solutions, driving market growth,”comments a Fact.MR analyst.

Speak to Research Analyst
https://www.factmr.com/connectus/sample?flag=AE&rep_id=5672

lab automation market

Key Segments Covered

  • Product
    • Equipment
      • Automated Workstations
      • Automated Liquid Handling
      • Automated Integrated Workstations
      • Pipetting Systems
      • Reagent Dispensers
      • Microplate Washers
    • Microplate Readers
      • Multi-mode Microplate Readers
      • Single-mode Microplate Readers
    • Automated ELISA Systems
    • Automated Nucleic Acid Purification  Systems
    • Software & Informatics
      • Workstation/Unit Automation Software
      • Laboratory Information Management Systems (LIMS)
      • Electronic Laboratory Notebook
      • Scientific Data Management System
  • Application
    • Drug Discovery
    • Clinical Diagnostics
    • Genomics Solutions
    • Proteomics Solutions
  • End User
    • Biotechnology & Pharmaceutical Industries
    • Research & Academic Institutes
    • Hospitals & Diagnostic Laboratories
    • Forensic Laboratories
    • Environmental Testing Labs
    • Food & Beverage Industry
  • Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

Full Access of this Report Is Available At
https://www.factmr.com/checkout/5672

Competitive Landscape

Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Hudson Robotics, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Hamilton Robotics, Bio-Rad Laboratories, bioMerieux SA, Becton Dickinson & Company, Qiagen NV, Danaher Corporation, and Hudson Robotics are some prominent lab automation equipment and software providers profiled in Fact.MR’s report.

  • With regard to solution offerings, Siemens Healthineers provides the SIMATIC SIPAT Process Analytical Technology, facilitating the right-first-time production via Quality by Design (QbD) transfer of previously downstream quality controls into the manufacturing process itself. The software helps healthcare settings become more flexible with regard to production expansion, new product launches, and entry into new markets.
  • Similarly, Bio-Rad Laboratories offers its CFX Automation System II, a robotic plate handler compatible with all CFX RT-PCR Detection Systems to enable walk-away, high throughput qPCR operation in a simplified format. This systems generates large volumes of data and rapid data analysis. It is ideally suited to meet the high throughput RT-PCR requirements of today’s drug discovery and screening workflows.

For More Insights
https://www.prnewswire.com/news-releases/waxes-and-polishes-remains-top-selling-automotive-aftermarket-appearance-chemicals-with-sales-growing-at-3-through-2031-concludes-factmr-301327989.html

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the global lab automation market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (equipment and software & informatics), application (drug discovery, clinical diagnostics, genomic solutions, and proteomics solutions), and end-user (biotechnology & pharmaceutical industries, research & academic institutes, hospitals & diagnostic laboratories, forensic laboratories, environmental testing labs, and food & beverage industry), across five major regions of the world.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

How has COVID-19 Spurred Demand for Pharmaceutical Waste Management: Check Latest Study

The demand for medical waste management is poised to expand steadily, growing at a CAGR of 5.1% across the forecast period (2020-2025).

As healthcare infrastructure has started to develop, the number of surgical procedures for treating various chronic and infectious diseases have also increased. This has necessitated the safe disposal of medical waste generated during the surgical process. Over the years, various governmental and non-governmental organizations have bolstered efforts to ensure the proper management of medical waste.

The Centers of Medicare and Medicaid Services (CMS) project that healthcare spending shall increase by 5.6% across the forecast period. As a result, healthcare settings have been outsourcing their medical waste management services to third parties, thus broadening the scope of the market. The ongoing coronavirus pandemic is also anticipated to leverage the need for proper medical waste disposal to avoid the spread of infection within healthcare settings.

To remain ‘ahead’ of your competitors, request a sample https://www.factmr.com/connectus/sample?flag=S&rep_id=4804

A detailed assessment of the medical waste management market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the medical waste management market along with their product portfolio enhances the reliability of this comprehensive research study.

Key Takeaways from the Medical Waste Management Market Study:

  • By nature, non-hazardous medical waste is anticipated to account for a major chunk of the medical waste management market. The segment is poised to capture a market share of nearly 70% across the forecast period.
  • By waste type, the infectious waste segment is expected to grow the fastest, at a CAGR of 6.0%. This is attributed to the growing prevalence of infectious diseases such as SARS, Hepatitis, Tuberculosis and influenza. However, the non-infectious segment shall remain dominant, owing to rising prevalence of chronic disorders in the wake of a rapidly aging population.
  • By waste generator, large quantity waste generators are poised to remain in the vanguard of the medical waste generators market. Hospitals constitute the major chunk of medical waste generators, owing to the large volume of surgical procedures happening in a day.
  • By service type, off-site waste management shall gain traction, attributed to stringent government regulations and increased burden of healthcare expenditure. Key healthcare settings have been outsourcing their waste management to outside parties.
  • Regionally, North America is set to dominate the market, capturing nearly 40% market share while Asia-Pacific is expected to be significantly leveraged. Stringent healthcare regulations are boosting medical waste management prospects in North America while a rapidly evolving healthcare infrastructure drives growth in the Asia-Pacific.

Speak To Research Analyst For Detailed Insights:  https://www.factmr.com/connectus/sample?flag=AE&rep_id=4804

Medical Waste Management: Market Segmentation

Fact.MR has studied the medical waste management market with detailed segmentation on the basis of nature of waste, type of waste, waste generator type, service type and region.

Nature of Waste

Type of Waste

Waste Generator Type

Service Type

Region
Non-hazardous Waste Sharps Large Quantity Waste Generators:

  • Hospitals (Public & Private)
  • Pharmaceutical & Biotechnology Companies
 On-site Waste Management North America
Hazardous Waste Infectious & Pathological Waste Mid & Small Quantity Waste Generators:

  • Clinics & Physicians’ Offices
  • Retail Pharmacy
  • Ambulatory Surgical Centers & Long-term Care Centers
  • Laboratories (Pathological & Diagnostic)
  • Academic & Research Institutions
  • Blood Banks
  • Others
 Off-site Waste Management Europe
Radioactive Waste Asia Pacific
Pharmaceutical Waste Latin America
Non-infectious Waste Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

For critical insights on this market, request for methodology here https://www.factmr.com/connectus/sample?flag=RM&rep_id=4804

Medical Waste Management Market: Analysis on Market Size Evaluation

The medical waste management market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for medical waste management is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent medical waste management market segments, along with market attractiveness evaluation, has been incorporated in the report.

Medical Waste Management Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the medical waste management report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the medical waste management market during the forecast period.

Country-specific valuation on demand for medical waste management has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

For More Insights:
https://www.biospace.com/article/radiation-proctitis-treatment-market-to-grow-at-7-percent-cagr-high-demand-for-oral-treatment-options-boosts-growth-fact-mr/

Medical Waste Management Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading providers of medical waste management services along with their detailed profiles. Essential and up-to-date data information related to market performers, who are principally engaged in the provision of medical waste management services, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis of each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the medical waste management market. Prominent manufacturers with established market presence in the medical waste management market are Stericycle Waste Management, Inc., Sharps Compliance, Inc., CLEAN HARBORS, INC., US Ecology, Inc., Medical Waste Solutions and Veolia.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Opthalmic OTC Drugs Drugs Is Anticipated Grow at a of CAGR of 4.2% by 2025

The global ophthalmic drugs market is anticipated grow moderately, at a CAGR of 4.2% during the forecast period (2020-2025). Visual impairments have increased across the world, owing to a multitude of factors. Varying in degree, visual impairments are a global health concern, affecting individuals physically and psychologically.

It is estimated that around 25% of the American population will suffer from cataract by 2020 while diabetic retinopathy patients will rise by nearly 20%. As a consequence, the demand for ophthalmic drugs is increasing. Moreover, rising FDA approvals for different drugs, such as Shire’s Xiidra, a lymphocyte function associated antigen-1 (LFA-1) antagonist, are leveraging market prospects.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4799

Key Takeaways of Global Ophthalmic Drugs Market Study:

  • By disease indication, the retinal disorders segment is set to dominate the ophthalmic drugs market. A burgeoning pool of retinal disorder patients is projected to leverage the segment’s market share. It is estimated that the number of people afflicted by age-related macular degeneration (AMD) hall reach 288 million by 2040. Projected market share of retinal disorders segment is pegged at 4.7% in the forecast period.However, the glaucoma segment is set to soar in popularity. This is attributed to a rising pool of glaucoma patients and the presence of important glaucoma drug manufacturers such as Pfizer and Novartis. The glaucoma segment is set to grow staggeringly at a CAGR of 3.5%, capturing two-fifth of the market.
  • By therapeutic class, the anti-glaucoma drugs segment is prophesied to capture a major chunk of the global ophthalmic drugs market. This is attributed to increasing prevalence, higher inclination towards combination methods and rising initiatives for treatment penetration. Also, industrial focus on development of glaucoma treatment drugs shall leverage the segment’s growth. Anticipated CAGR for anti-glaucoma drugs is 3.3% and a market share of over two-fifths.
  • By product type, over-the-counter drugs (OTC) segment is anticipated to be the most attractive of the global ophthalmic drugs market. OTC drugs are suitable for the treatment of seasonal infections such as conjunctivitis and dry eyes. These drugs also offer relatively short duration treatment. The OTC drugs segment shall dominate the global ophthalmological drugs market, accounting for more than half of the total market share.
  • By distribution channel, independent pharmacies and drug stores are anticipated to expand rapidly at a CAGR of 4.8%, capturing a market share of more than half the total ophthalmological drugs market. The high growth rate is due to its convenience, security, electronic payment technology and a wide range of available medications and services.
  • By region, North America shall capture almost two-fifth of the global ophthalmological drugs market during the forecast period. This is attributed to high cost of prescription drugs and presence of key market players such as Novartis AG and F. Hoffmann- La Roche, Ltd. Asia-Pacific is anticipated to expand modestly at a CAGR of 4.9%, attributed to increase in funding for research and presence of key market players in the wake of a large patient pool.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4799

global ophthalmic drugs market value and growth forecast by disease indication

Global Ophthalmic Drugs Market Segmentation

Fact.MR has studied the global ophthalmic drugs market with detailed segmentation on the basis of disease indication, therapeutic class, product type, distribution channels and regions.

Disease Indication

  • Dry Eye
  • Glaucoma
  • Infection/Inflammation
  • Retinal Disorders:
  • Wet AMD
  • Dry AMD
  • Diabetic Retinopathy
  • Others
  • Allergy
  • Uveitis
  • Others

Therapeutic Class

  • Anti-inflammatory Drugs:
  • NSAIDs
  • Steroids
  • Anti-infective Drugs:
  • Anti-fungal Drugs
  • Anti-bacterial Drugs
  • Others
  • Anti-glaucoma Drugs:
  • Alpha Agonist
  • Beta Blockers
  • Prostaglandin Analogs
  • Combined Medication
  • Others
  • Anti-allergy Drugs
  • Anti-VEGF Drugs
  • Others

Product Type

  • Prescription Drugs
  • OTC Drugs

Distribution Channels

  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies & Drug Stores

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4799

 

Following Questions Answers Covered in the Report are:

  • How will the global Opthalmic Drugs Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Opthalmic Drugs Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Opthalmic Drugs Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –http://www.globenewswire.com/en/news-release/2018/07/12/1536346/0/en/Global-Automotive-Actuators-Market-Projected-to-Reach-US-19-801-6-million-value-by-2022-end.html

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Sales of Nasal Drug Delivery Systems Is Anticipated to Register a CAGR Growth of 7% by 2025

The ongoing COVID-19 pandemic is set to leverage the global drug delivery systems market, expanding at a CAGR of 7.0% between 2020 and 2025. As the number of infections rise exponentially on a daily basis, healthcare providers are grappling with rising shortfalls in the provision of essential medical equipment such as respirators and ventilators.

As a result, key players in the industry have scaled up their production in order to meet shortages. The easing of nationwide lockdowns and lifting of travel restrictions is anticipated to regenerate production cycles and supply chains, thus restoring the supply of drug delivery systems. In addition, the utilization of drug delivery systems for gene therapy will leverage the global drug delivery systems market.

For detailed insights on enhancing your product footprint, request a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4768

The ongoing COVID-19 pandemic is set to leverage the global drug delivery systems market, expanding at a CAGR 7%.

between 2020 and 2025. As the number of infections rise exponentially on a daily basis, healthcare providers are grappling with rising shortfalls in the provision of essential medical equipment such as respirators and ventilators.

As a result, key players in the industry have scaled up their production in order to meet shortages. The easing of nationwide lockdowns and lifting of travel restrictions is anticipated to regenerate production cycles and supply chains, thus restoring the supply of drug delivery systems. In addition, the utilization of drug delivery systems for gene therapy will leverage the global drug delivery systems market.

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4768

global drug delivery systems market 01

Global Drug Delivery Systems: Market Segmentation

Fact.MR has studied the global drug delivery systems market with detailed segmentation on the basis of delivery system, route of administration, application and region.

Delivery System

  • Intra Uterine Implants
  • Pro-drug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery

Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

Application

  • Infectious Disease
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Takeaways of Global Drug Delivery Systems Market Study:

By delivery type, targeted drug delivery shall grow at a CAGR of 6.8%, accounting for almost half of the global drug delivery systems market. However, polymeric drug delivery is expected to grow the fastest at the rate of 7.3% during the forecast period. Use of nanotechnology and localized drug delivery are key growth drivers for both segments.
By application, the oncology segment shall expand the fastest at a CAGR of 7.5% while the CNS segment shall grow at a CAGR of 6.9%. Rising prevalence of cancer and neurological disorders have boosted the demand for enhanced drug delivery devices, thus boosting the overall market share.

By route of administration, the injectables segment shall capture a major chunk of the global drug delivery systems market, constituting 44.6% market share. The oral segment is close behind, capturing nearly 2/5th of the global drug delivery systems market. Faster drug delivery at the affected site drives the growth of the injectables segment while advancements in oral drug formulations such as solid lipid nanoparticles shall drive the growth of the oral drugs segment.
By region, North America shall dominate the global drug delivery systems market, capturing nearly 40% of the market. At the same time, Asia-Pacific shall expand the fastest, at a CAGR of 7.8% across the forecast period. Increasing prevalence of acute chronic infections, introduction of advanced drug delivery devices and systems and favorable reimbursement policies for key players shall drive growth in both regions.

“Introduction of nanotechnology, coupled with three-dimensional printing and strengthening of existing and new drugs are poised to act as important growth stimulators of the global drug delivery systems market. Key manufacturers are exploiting the available opportunities to consolidate their foothold within the market,” concludes a Fact.MR analyst.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4768

Presence of Several Global & Local Market Players to Heat up Market Competition:

The global drug delivery systems market is characterized by the presence of a large number of global and local manufacturers. Prominent players include, but are not limited to, the following: Novartis AG, Pfizer, Inc., Baxter International, Inc., Bayer AG Boston Scientific Corporation, Johnson and Johnson Services, Inc., Amgen, Inc., and F. Hoffmann La-Roche Ltd. Development of new drug delivery systems and addressing anomalies among existing ones are important expansion strategies adopted by the important market players.

For instance, Novartis AG has acquired a patent to develop thermogelling peptide delivery systems in February 2020. In addition, the company currently offers the Binocrit and ZYKADIA drugs for treating symptomatic anemia associated with renal failure and treatment of non-small lung cancer. Pfizer, Inc., another prominent market player, provides the iSecure, ABBOJECT and CARPUJECT syringe systems. Additionally, it also offers IV drug delivery systems such as the ADD-Vantage ADDaptor delivery system.

For More Insights: https://www.biospace.com/article/increased-healthcare-spending-and-technological-advancements-are-shaping-future-of-waldenstrom-macroglobulinemia-market-finds-fact-mr/

Looking for more information?

The research study on the global drug delivery systems market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global drug delivery systems market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of delivery system (intra-uterine implants, pro-drug implants, polymeric drug delivery, and targeted drug delivery), route of administration (oral, injectable, inhalation, transdermal, ocular, nasal and topical) and application (infectious disease, oncology, ophthalmology, urology, diabetes, CNS and others) across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Immunodermatology Market Expecting the Unexpected future in 2031; SWOT analysis, investment feasibility analysis

According to a report by Fact.MR, the immunodermatology market is expected to post significant gains through 2021 and beyond. Expansion of the market is underpinned by growing prevalence of skin disorders such as atopic dermatitis, psoriasis, and other conditions. The market is anticipated to witness an unprecedented upsurge through 2031, with surging cases of incurable and rare skin disorders, especially among children.

According to the report of Genetic and Rare Diseases, around 900 million people are suffering from skin disorders since 2018. Among which, approximately 9.6 million children were affected with atopic dermatitis in 2020 and over 31.6 million people in the U.S. have some form of eczema. Acknowledging this burden, healthcare professionals are increasing research & development activities in manufacturing novel drugs, stimulating the demand for immunodermatology. Hence, rising demand for drug therapies and product approvals are some of the factors augmenting market growth.   

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=5649

According to the study, increasing investment in development of novel pipeline drugs is expected to provide lucrative growth opportunities for the key players over the coming years. Also, growing demand for effective skin treatment and fast-track drug approval for novel immunodermatological drugs across emerging economies such as India, China and Japan is aiding the demand.

“Growing willingness to adopt high-quality and cost-effective treatments and increasing awareness regarding skin disorders are creating opportunities for early diagnosis of various skin conditions. This is expected to create attractive opportunities for growth,” says the Fact.MR analyst.

Key Takeaways from Fact.MR’s Immunodermatology Study

  • By type, atopic dermatitis is expected to account for major chuck of share in the global immunodermatology market, psoriasis catching up
  • By diagnosis, immunofluorescence testing is likely to remain primary choice for medical practitioners
  • Demand for drug therapy and gene therapy are expected to experience major incline
  • High demand for immunodermatological drugs likely in the US market, owing to rising cases of atopic dermatitis
  • Fast-track drug renewals and approvals are anticipated to widen sales prospects across the UK
  • Germany is expected to emerge as Europe’s leading immunodermatology market through 2021 and beyond
  • India and China are expected to lead the Asia Pacific immunodermatology market backed by the rising cases of dermatitis among children

Prominent Drivers

  • Rising incidence of allergies and skin diseases is expected to bolster the demand of immunodermatology
  • Surging demand for effective therapies and dermatological drugs for treating skin disorders will boost the market growth
  • Increasing healthcare expenditure and growing research activities for novel drug development for skin disorders will drive the demand

Discover more about the immunodermatology market with figures and data tables, along with the table of contents. https://www.factmr.com/connectus/sample?flag=T&rep_id=5649

Key Restraints

  • Documented side-effects and allergies arising out of skin diseases medicine consumption are likely to hinder future sales prospects
  • Stringent regulatory provisions regarding drug approvals is limiting adequate availability in the market

Competitive Landscape

Prominent Immunodermatology market players profiled by Fact.MR include Novartis AG, Abbvie, Valeant Pharmaceuticals, Bausch Health, Glenmark Pharmaceuticals Inc., Astellas Pharma, Novopharm Limited, Aspen Pharmacare Inc., Prometheus Laboratories, Taro Pharmaceuticals Inc., and Nucare Pharmaceuticals Inc. Key players are adopting various strategies such as mergers & acquisition, and are launching new products to strengthen their position in the industry.

For instance, in April 2020, KSL Biomedical Inc., a leading developer of novel companion diagnostic & therapeutic applications for immunology and oncology, announced the acquisition of Beutner Laboratories, an innovator in immunodermatology.

Also, Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, in December 2020 announced continued progress and future growth drivers related to its immuno-dermatology platform and pipeline on Virtual Investor Day to expand the company’s product portfolio.

More Insights on the Immunodermatology Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global immunodermatology market. The study divulges compelling insights on the market based on type (systemic sclerosis, dermatomyositis, psoriasis, vitiligo, alopecia areata, lichen sclerosus, allergic dermatitis, atopic dermatitis, lupus erythematosus, blistering diseases, and connective tissue diseases), diagnosis (immunofluorescence testing, biopsy and blood test), therapy (drug therapy, intensed pulsed light therapy, stem cell therapy, and gene therapy), mode of administration (oral, topical, and intravenous) across key regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/increasing-and-consistent-investments-for-healthcare-infrastructural-development-is-key-for-driving-neuralgia-treatment-market/

Explore Fact.MR’s Coverage on the Healthcare Domain

Dermatology Devices Market: A recent report by Fact.MR provides an in-depth analysis about the global dermatology devices market for the forthcoming decade.

Dermatology Diagnostic Devices Market: The scope of this Fact.MR’s report is to analyze the global dermatology diagnostic devices market for the upcoming forecast period, and provide readers an unbiased and accurate analysis.

Necrotizing Skin Infections Treatment Market: A recent study by Fact.MR on the necrotizing skin infections treatment market offers a forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Originator Small Molecule Drug Market is anticipated to show a robust growth rate during the forecasted period of 2021-2031

Evolving need for drug targets to treat cancer, epilepsy, diabetes and various other dreaded diseases is set to provide lucrative opportunity for small molecule drug demand. The use of diverse originator small molecule drugs varying from different humane ailments such as cold, cough and fever to attract huge customer engagement and make market get propelled.

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing Demand of Originator Small Molecule Drug. The new Originator Small Molecule Drug market analysis report outlines the key factors that will impact sales, production and supply during the assessment 2021-2031. The report highlights the Originator Small Molecule Drug market key trends that are expected to influence the overall dynamics, and Originator Small Molecule Drug market size and share.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=1519

Key Segments

By Drug Class

  • Anticholinergic
  • Anti-cancer
  • Others

By Indication Type

  • Cardiovascular
  • Oncology
  • Diabetes
  • Immunological disorders
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Clinics

Key questions answered in Originator Small Molecule Drug Market Survey Report:

  • What is the current scenario and key trends in Originator Small Molecule Drug Market?
  • What are the key strategies companies are adopting to increase their consumer base?
  • What are the key categories within the Originator Small Molecule Drug segments and their future potential?
  • What are the major Originator Small Molecule Drug Market drivers and their expected impact during the short, medium, and long terms?
  • What is the Originator Small Molecule Drug Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1519

Who are the Key Manufacturers and Suppliers of Originator Small Molecule Drug?

Some of the leading manufacturers and suppliers of originator small molecule drugs include

  • Roche
  • Genentech
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Gilead
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc.
  • Others

The majority of the industry giants in the originator small molecule drug industry have held a creative product range and offer highly effective drugs. Manufacturers choose to play with organic market strategy by innovating new production technologies &some other hybrid strategies to reach a clientele and gain a competitive edge over competitors. Manufacturers are also observed to expand their capacity and geographical presence to reinforce their position.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

North America to remain the Supreme Region

The United States is one of the world’s biggest markets for small molecule drug. During the time frame 2021-2031, the US small molecule drug market is expected to emulate huge push. As the demand for drugs to treat various diseases is on highly increasing note, market is expected to show huge growth in the coming years.

Canada to also project huge spending on development of originator small molecule drug owing to the inclination of governing bodies towards huge expenditure allocation to healthcare system and to facilitate various drugs to treat different diseases. North America as a region with highly favorable reimbursements to remain as the most dominating globally.

Read More Trending and Similar Reports from Fact.MR – http://www.globenewswire.com/en/news-release/2018/01/16/1289681/0/en/6-Key-Takeaways-from-Fact-MR-s-Report-on-MDM-BPO-Market-for-Forecast-Period-2017-2026.html

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Tumor Embolization Market: North America is expected to be the leading region says Fact.MR Report

The global tumor embolization market study, currently being undertaken by consulting firm Fact.MR, forecasts a relatively positive growth outlook for FY 2021-22, compared to the previous year. Resumption of embolization procedures on a larger scale in the aftermath of the coronavirus pandemic are largely expected to restore the said projections

According to Fact.MR’s study, tumor embolization sales are heavily reliant on surging treatment volumes for liver cancers. The American Cancer Society’s estimates for primary liver cancer and intrahepatic bile duct cancer in the US for 2021 include over 42,000 new diagnoses and over 30,000 fatalities. This signifies an over threefold increase in incidence rates and doubling of death rates since 1980.

Consequently, healthcare expenditure to address the same is increasing manifold. A recent study discovered that overall direct costs for patients with hepatocellular carcinoma (HCC) ranged from US$ 29,355 to US$ 58,529, with median costs pegged at US$ 176,456 per patient annually. Majority of these expenses are directed towards availing tumor embolization treatments, expanding growth prospects.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=3997

Key Takeaways from Fact.MR’s Tumor Embolization Market Study

  • Tumor embolization microcoils are expected to grab major eyeballs amid heightened safety concerns
  • By indication, tumor embolization for paraganglioma is likely to capture the maximum revenue share
  • Cancer treatment centers are poised to emerge as one of the most extensive tumor embolization end-users
  • US to record impressive sales amid growing diagnosis and treatment procedures for skin cancers
  • Rising Yttrium-90 redioembolization procedures to treat liver cancers driving sales across UK
  • Rising cancer research and treatment initiatives catapulting tumor embolization sales across Germany and France
  • India and China to garner lucrative market shares, driven by rising surgical procedures to treat breast and colorectal cancers

Tumor Embolization Market- Prominent Drivers

  • Increasing prevalence of oncogenic and non-oncogenic tumors accelerating tumor embolization sales across the world
  • Nanotechnology based embolization procedures, including microspheres or microbeads, are widening growth prospects
  • Ever-widening scope of interventional oncology is opening doors for tumor embolization market revenue expansion

Tumor Embolization Market- Key Restraints

  • Mixing of microbeads with radioactive isotopes to destroy malignant cells may also damage healthy tissue, limiting uptake
  • High risks of surgical laceration infections made during the embolization process is likely to restrain growth

Discover more about the tumor embolization market with figures, data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/3997/tumor-embolization-market

Competitive Landscape

Microvention Inc., Kaneka Pharma Europe NV, Penumbra Inc., DePuy Synthes, Cook Medical, Deutschland GmBh & Co. KG, Boston Scientific Corporation, Balt Extrusion, AngioDynamics and Varian Medical Systems Inc. are some highly prominent tumor embolization manufacturers profiled by Fact.MR’s ongoing study. A combination of organic expansion strategies such as product launches and approvals, as well as inorganic approaches such as acquisitions, partnerships and collaborations are also relied upon.

  • In January 2021, Microvention Inc. announced the FDA approval of the PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for treating intracranial wide neck bifurcation aneurysms. This system is designed with the latest microbraid technology, featuring a lower profile delivery system compatible with the VIATM 17 micro catheter and includes additional device configurations.

Also, Penumbra Inc. manufactures the Penumbra SMART COIL® System, equipped with Ultra HD Fiber which is designed to be 3x stronger and 3x more flexible than polypropylene. It also features a single click instant mechanical detachment system for ease of use and reliability. It is used for a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.

More Insights on the Tumor Embolization Market

In its ongoing study, Fact.MR offers unbiased analysis of the global tumor embolization market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (NBCA glue, microspheres or microbeads and microcoils), indication (hemangioblastoma, juvenile nasal angiofibroma, meningioma, aneurysmal bone cyst, paraganglioma, hemangiopericytoma & others) and end users (hospitals, intensive care units, surgical centers and cancer treatment centers) across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/latest-insights-on-nano-healthcare-technology-market-post-covid-fact-mr-new-report-analyzes/

Explore Fact.MR’s Coverage on the Healthcare Domain

Kidney Cancer Diagnostics Market: The report on the global kidney cancer diagnostics market discusses such key factors that govern the economics of kidney cancer diagnostics across the globe.

Colorectal Cancer Diagnostics Market: The report on the global colorectal cancer diagnostics market discusses such key factors that govern the economics of colorectal cancer diagnostics across the globe.

OTC Herbal and Traditional Medicines Market: Traditional and herbal medicines have played an indispensable role in fulfilling the requirements of global healthcare. The consumer healthcare has been undergoing transformations, with principles of herbal and traditional medicines being rediscovered and introduced in the market. Growing consumer concerns related to health effects of synthetic drugs is expected fuel adoption of herbal and traditional medicines.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Endoscope Tip Protectors Market foreseen to grow exponentially over 2019 to 2029

In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global endoscope tip protectors market considering 2019–2029 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities and trends affecting market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.

The endoscope tip protectors market study outlines the key regions – North America, Latin America, APEJ and Japan – along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing and gross margin. Prominent players covered in this research are Medtrica Solutions Ltd., Meditech Endoscopy, Aspen Surgical, Medline Industries, Inc., and Olympus etc.

To Remain ‘Ahead’ Of Your Competitors, Request For A Sample – https://www.factmr.com/connectus/sample?flag=B&rep_id=3984

The endoscope tip protector’s market report addresses the below-mentioned queries:

  • Why are vendors shifting away from traditional methods of manufacturing endoscope tip protectors market?
  • How does the global endoscope tip protectors market looks like in the next five years?
  • Which end use industry is expected to surpass segment by the end of 2029?
  • What innovative products are being introduced by the players in the global endoscope tip protectors market?
  • Which regions are showing the fastest market growth?

On the basis of product type, the endoscope tip protectors market study consists of

  • Semi Rigid Mesh Protectors
  • Eye Piece Protectors

On the basis of end user, the endoscope tip protectors market study incorporates:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Crucial insights in the endoscope tip protectors market research:

  • Underlying macro- and microeconomic factors impacting the growth of the endoscope tip protectors market.
  • Basic overview of the endoscope tip protectors market, including market definition, classification, and applications.
  • Scrutinization of each endoscope tip protectors market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend of endoscope tip protectors market across various industries.
  • Important regions and countries offering lucrative opportunities to endoscope tip protectors market stakeholders.

Get Customization on this Report for Specific Country: https://www.factmr.com/connectus/sample?flag=B&rep_id=3984

Endoscope Tip Protectors Market: Key Players

There are many key players manufacturing endoscope tip protectors. The companies manufacturing various endoscopic tip protectors are focusing on developing new and advanced products. Also, mergers, acquisitions and partnerships are the major strategies adopted by the key players. Examples of some of the key players operating in the global endoscope tip protectors market are

  • Medtrica Solutions Ltd.
  • Meditech Endoscopy
  • Aspen Surgical
  • Medline Industries, Inc.
  • Olympus etc.

Endoscope Tip Protectors Market: Regional Outlook

Geographically, the global endoscope tip protectors market is segmented into few key regions i.e. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East and Africa. North America is expected to be the dominant market in the global endoscope tip protectors market due to technological advancements and presence of well-established healthcare infrastructure.

Europe is expected to register a large revenue share in the global endoscope tip protectors market throughout the forecast period. Countries like India, China are expected to show a significant growth in the endoscope tip protectors market due to increasing number of hospitals and increasing number of surgeries.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/long-term-disability-management-to-drive-bulk-of-medical-case-management-services-market-growth/

Explore Fact.MR’s Coverage on the Healthcare Domain

Bone Growth Stimulator Market: A recent study by Fact.MR on the bone growth stimulator market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth.

Bone Marrow Processing System Market: Fact.MR gives a detailed assessment of bone marrow processing system market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Injectable Bone Graft Substitutes Market: Fact.MR delivers an in-depth analysis on global injectable bone graft substitutes market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Freezing Bags Market to Witness a Tremendous Growth Due to COVID-19 Pandemic – Exclusive Report by Fact.MR

The global freezing bags market is exhibiting steady growth and the trend is expected to continue for the forecast period between 2021 and 2031.

Rising demand for packaged food and growing disposable income of consumers are some of the key factors, fueling the freezing bag market growth across the globe. Besides this, increasing use of freezing bags for fruit, vegetables, and meat industries has created opportunities for growth of the global market for freezing bags, as per a study by Fact.MR.

Despite the growth, the COVID-19 outbreak had a major impact on the world economy. The pandemic had caused severe economic destruction due to the closure of manufacturing units and choked supply chain and logistics. Nonetheless, pharmaceutical and food industries are expected to emerge stronger as governments slowly ease restrictions imposed. With demand forecast to rise in the future, sales of freezing bags will continue rising at a positive rate.

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=5189

Key Takeaways

  • The U.S exhibits high growth in the global freezing bags on the back of sophisticated lifestyles of the people and the growing food industry.
  • Growing urban population and increasing consumption of packaged food are the factors driving the growth of the freezing bags market in the U.K.
  • In terms of region, Asia Pacific is expected to dominate the freezing bags market due to its large consumer base and increasing inclination towards processed and frozen foods.
  • The Middle East and Africa are expected to be the least market growth segment owing to the less adaptability of the freezing bags.

 

Key Drivers

  • Changing lifestyles and the growing spending power of consumers across the globe are the factors fueling the demand for freezing bags.
  • Increasing number of retail stores across the globe is propelling the market growth in a positive way.
  • Rising purchasing power of the middle-class population in developing countries will push the sales of freezing bags in the market.

Key Restraints

  • Rising awareness among people to stop the use of plastic may hinder the market growth of freezing bags.
  • Growing regulations to prohibit the use of plastic may pose a challenge for growth for the global market of freezing bags.
  • Strict regulations and policy measures implemented by the government are restraining the growth freezing bag market.

Explore tables and figures of the study. Request ToC of the report at

https://www.factmr.com/connectus/sample?flag=T&rep_id=5189

Competitive Landscape

Prominent players in the freezing bag market include S. C. Johnson, Great American Packaging, The Glad Products Company, Reynolds Consumer Products, Elevate Packaging, Weston, NatureWorks, Rutan Poly Industries, Inc., Star Poly Bag, Inc., Abbey Polythene, Maxpak Australasia, Falcon Pack, Novamont, Convex Innovative Packaging among others. Some of them are investing in product developments and acquiring other companies to strengthen their presence. For instance,

  • In January 2021, Novamont acquired the complete BioBag Group which helped Novamont to expand its boundaries to North America, Australia, and North-Eastern Europe.
  • In September 2020, NatureWorks announced manufacturing technology projects which assisted NatureWorks to increase the availability of Ingeo (PLA) biomaterial portfolio.

More Insights on the Freezing Bag market:
In its latest report, Fact.MR offers an unbiased analysis of the freezing bag market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (reusable and disposable), material type (High-Density Polyethylene (HDPE), Medium Density Polyethylene (MDPE), and Low-Density Polyethylene (LDPE)), distribution channel (pharmaceutical industry, chemical industry, and food industry), distribution channel (offline stores and online stores), and across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Read More Trending Reports of Fact.MR : https://www.biospace.com/article/growing-requirement-of-research-activities-to-fuel-demand-for-chromatography-syringes-market-states-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain
Shelf Stable Packaging Market: Fact.MR gives a detailed assessment of shelf stable packaging market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Conductive Plastic Compounds Market: Fact.MR’s expansive conductive plastic compounds market report sheds light on the prominent dynamics expected to shape future growth. The study explicates on the prominent drivers, opportunities and trends prevailing across key segments in prominent end users. Also, information regarding prominent key players has been embedded in the report.

Plastic Protective Packaging Market: Fact. MR’s extensive coverage on plastic protective packaging market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
 

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
 

Categories
Pharmaceutical

Asthma Spacers Market is poised to surpass US$ 1803.9 Mn by 2031-end

The global asthma spacers market is expected to grow moderately, at a CAGR of 3.9% between 2020 and 2026. The proliferation of respiratory illnesses such as asthma and allergies on back of pollution and smoking is paving the way for high demand growth of asthma spacers.  The geriatric population of the world is increasing rapidly and is exhibiting heightened disposition for respiratory disorders. Projections indicate that by 2050, more than one-fifth of the world’s population shall constitute the elderly.

Consequently, the number of asthma patients shall increase manifold. The World Health Organization predicts that by the end of 2025, an additional 100 million people shall contract asthma. At present, around 235 million people are affected by asthma. On the back of the aforementioned factors, the market shall surpass a value of US$ 1.8 Bn by the end of the forecast period. Moreover, difficulties using metered dose inhalers (MDI) is expected to further leverage the asthma spacers market.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4596

Key Takeaways of Asthma Spacers Market Study
  • Aerochambers shall gain significant traction during the forecast period. The segment shall account for more than two-fifth of the market share of the asthma spacers market. Delivery of medicine in a regulated manner and minimum wastage are key factors driving market growth.
  • Micro-spacers and flexi chambers are anticipated to exhibit moderate growth, accounting for a CAGR of 3.9% during the forecast period.
  • North America is set to remain the most attractive market for asthma spacers. A market share of 41% is predicted for the region during the forecast period, surpassing a valuation of US$ 739.61 Mn.
  • Asia-Pacific is catching up, expanding moderately at a CAGR of 4.5%. Burgeoning population, combined with increased expenditure on healthcare are key drivers behind the expansion of the asthma spacers market in the region.

global asthma spacers market 02 by FactMR

“The global asthma spacers market shows significant potential in the future. Growing incidence of asthma among the elderly, combined with a burgeoning population are contributing immensely to the expansion of the asthma spacers market,” concludes a Fact.MR analyst.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=4596

Product Launches and Spontaneous Innovation to Determine Competition Landscape

The global asthma spacers market is highly fragmented. A number of small and large-scale companies operate in the market. The dominant players’ invest heavily in acquiring research and development businesses of smaller companies. Moreover, they also focused on launching new products. For instance, Trudell International invests in continuous innovation in order to broad base its market footprint. Its AEROCHAMBER PLUS FLOW-VU ensures that medicine is delivered where it is required. It consists of a dedicated inhalation indicator which helps co-ordinate actuation with inhalation. Another market player, Medical Developments International, focuses on spontaneous technological innovation to develop patient-friendly markers. For example, the company’s Anti-Static Compact Space Chamber Plus, is equipped with a Cross Valve Technology. This ensures proper delivery of medicine to asthma patients by providing low-resistance, one-way inhalation flow.

Get More Insights- https://www.biospace.com/article/asthma-spacers-demand-impacted-by-increased-incidences-of-asthma-says-fact-mr/

Looking for more information?

The research study on the asthma spacers market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global asthma spacers market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of product type (Aerochambers, Optichambers, Volumatic, Inspirease and Others) and distribution channel (Retail Pharmacy, e-Commerce and Hospital Pharmacy) across five major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4596/asthma-spacers-market
Press Release: https://www.factmr.com/media-release/1368/global-asthma-spacers-market
Follow Us: LinkedIn | Twitter